Form4insider filings, from the source

SEC Form 4 · accession 0001144204-17-062471

Ensysce Biosciences, Inc. · ENSC

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owners
A Lorne Weil
Officer — Executive Chairman · Director
Period of report
Dec 5, 2017
Accepted (ET)
Dec 5, 2017 · 6:56 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001716947

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockF1,F2Dec 5, 2017J187,166$0.00D307,545D
Common StockF3,F4,F5Dec 5, 2017J169,517$0.00D1,000,000ISee Footnote

Table II — derivative securities

No Table II lines on this filing.

Explanation of responses